08.02.2013 Views

functional medicine and nutritional genomics - American Association ...

functional medicine and nutritional genomics - American Association ...

functional medicine and nutritional genomics - American Association ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS<br />

Another possible measure of intestinal permeability in<br />

the small bowel is the oral lactulose/mannitol challenge<br />

test (69). In this <strong>functional</strong> assay, a patient<br />

consumes a st<strong>and</strong>ard amount of a solution of mannitol,<br />

a sugar alcohol, <strong>and</strong> the disaccharide lactulose in a<br />

hyperosmolar solution. Individuals with increased gut<br />

permeability of the small bowel absorb more lactulose,<br />

which is not metabolized <strong>and</strong> excreted in the urine,<br />

than individuals whose mucosa is normal. Mannitol, on<br />

the other h<strong>and</strong>, is translocated at a relatively fixed rate<br />

in all individuals. Thus an increased ratio of lactulose<br />

to mannitol in the urine indicates enhanced intestinal<br />

permeability (69).<br />

Conducting a fecal calprotectin evaluation is another<br />

test for measuring intestinal inflammation (70,71).<br />

Calprotectin is a calcium-binding protein found in the<br />

following types of white blood cells: neutrophilic<br />

granulocytes, monocytes, <strong>and</strong> macrophages (70).<br />

Calprotectin resists metabolic degradation <strong>and</strong> can be<br />

measured in the feces. The fecal calprotectin test<br />

makes use of the fact that the release of calprotectin<br />

in the stool is associated with damage to the GI<br />

mucosa <strong>and</strong> increased inflammatory processes (71).<br />

b. Nutritional Influences in IBD<br />

A variety of nutrients have been found to be deficient<br />

in CD patients. Causes include malabsorption in the<br />

small intestine, increased nutrient need because of<br />

disease activity, low nutrient intake, nutrient loss due<br />

to chronic diarrhea or increased transit time or effect<br />

of medications. One study examining multiple nutrient<br />

deficiencies found 85% of 279 CD patients had<br />

deficiencies. Nutrients most frequently found deficient<br />

were iron, calcium, zinc, protein, Vt. B12 <strong>and</strong> folate<br />

(72).<br />

It has recently been suggested that certain protective<br />

nutrients <strong>and</strong> <strong>functional</strong> foods can provide protection of<br />

the gut mucosa from the CARD15/NOD2 related<br />

Th1-dominant inflammatory reactions (73). The amino<br />

acids glutamine <strong>and</strong> arginine, the essential<br />

micronutrients vitamin A, zinc, vitamin E <strong>and</strong> the B<br />

vitamin, pantothenic acid are among these protective<br />

nutrients. Evidence indicates that chronic H. pylori<br />

infection is associated with elevated oxidative stress in<br />

the intestinal mucosa, with increased levels of plasma<br />

lipid peroxides <strong>and</strong> other markers of free radical injury<br />

94<br />

2012<br />

(74). Therefore, supplementation with antioxidants,<br />

including ascorbic acid, tocopherol, <strong>and</strong> food flavinoids<br />

like quercetin (found in apples) <strong>and</strong> epicatechin<br />

gallate (from green tea), may be beneficial. Shapiro<br />

et al. (75) discusses the addition of polyphenols to<br />

artificial <strong>nutritional</strong> formulas to improve the outcome of<br />

patients with IBD. Five polyphenols in particular have<br />

shown in animal <strong>and</strong> human studies to have benefit in<br />

IBD by reducing inflammation associated with variations<br />

of the CARD15/NOD2 <strong>and</strong> SLC22A4/A5 genes:<br />

Boswellia, curcumin, epigallocatechin, quercetin, <strong>and</strong><br />

resveratrol (75-84). Prebiotics <strong>and</strong> probiotics are also<br />

important substances that support proper function of the<br />

GALT <strong>and</strong> lead to the repair phase of gastrointestinal<br />

restoration (73).<br />

Buddington <strong>and</strong> Weiher (85) proposed that, in<br />

managing <strong>functional</strong> gastrointestinal disorders, the GI<br />

system should be viewed as a flow system or ‚river‛.<br />

The GI tract is a complex ecological system that flows<br />

from top to bottom <strong>and</strong> requires nourishment to create<br />

the appropriate ‚ecology‛ within the small <strong>and</strong> large<br />

intestines (85).<br />

c. Putting It All Together With The Functional<br />

Medicine ‚4R TM ‛ GI Restoration Program<br />

There is a slow-moving but growing awareness that<br />

underst<strong>and</strong>ing the etiology at the genetic-molecularenvironmental<br />

level may be just as important if not<br />

more important than disease classification. ‚Functional<br />

Medicine‛ – an evidence based systems biology<br />

approach addresses this concept of underlying etiology<br />

<strong>and</strong> root cause solutions <strong>and</strong> is now being encouraged<br />

by the National Institutes of Health under the new<br />

program NIH Roadmap, a route to accelerate medical<br />

discoveries that will improve health (86). In essence,<br />

<strong>functional</strong> <strong>medicine</strong> assessment is concerned with<br />

underst<strong>and</strong>ing the antecedents, triggers, <strong>and</strong> mediators<br />

of dysfunction that give rise to molecular imbalances<br />

underlying the signs <strong>and</strong> symptoms of disease (6).<br />

The following is a brief adaptation of the ‚4R TM GI<br />

Restoration Program‛ that the Institute for Functional<br />

Medicine pioneered for the management of gut<br />

dysfunction <strong>and</strong> chronic disease. (6,87). It is a<br />

conceptual framework with which to target therapies<br />

aimed at improving GI function.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!